News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Riad G. Dirani, PhD

Articles by Riad G. Dirani, PhD

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study

ByWilliam H. Herman, MD, MPH,Riad G. Dirani, PhD,Ruslan Horblyuk, MBA,M. Colleen O'Neill, BSc,Barbara Kravitz, MS,Mark A. Heise, PhD,Alan Bakst, PharmD, MBA,Martin I. Freed, MD,the RESULT St

April 1st 2005

Latest Updated Articles

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study
Published: April 1st 2005 | Updated:

Trending on AJMC

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy

Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL

The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD

Faricimab Brought Early Control of Some Symptoms in AMD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.